Lymph nodes can predict survival in patients with esophageal cancer
Optimal methods for predicting treatment efficacy in patients with esophageal cancer are seriously lacking. But now, researchers from Japan have […]
Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. The […] One of the most successful interventions in reducing infectious disease worldwide, vaccination still has limited effectiveness in protecting one group […] Like airport security barriers that either clear authorized travelers or block unauthorized travelers and their luggage from accessing central operation […] Scientists from Trinity College Dublin have discovered how the highly infectious and sometimes deadly Hepatitis C virus (HCV) “ghosts” our […] A team of Brazilian researchers has developed a strategy that slows the growth of triple negative breast cancer cells by […] A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded […] The immune system is an important defender against cancer. Immune cells continuously search the body for disease and use their […] A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity and had […] In a paper published in the journal Nature, an international research team led by researchers at Karolinska Institutet in Sweden […]Lymphoma
Cancer device created to see if targeted chemotherapy is working: Artificial intelligence and biosensors can rapidly detect if live cancer cells remain after treatment
Breaking the code: How is a mother’s immunity transferred to her baby? Factors contributing to placental transfer of antibodies
Enhanced human Blood-Brain Barrier Chip performs in vivo-like drug and antibody transport
How hepatitis C ‘ghosts’ our immune system
How to starve triple negative breast cancer
Humanization of antibodies targeting human herpesvirus 6B
One way T cell function may fail in cancer: The protein Chop inhibits anti-tumor immunity in CD8+ T cells
Mesothelin-targeted CAR T-cell therapy shows early promise in patients with solid tumors
New mechanism of bone growth discovered